Latest Headlines

• 

  3 Healthcare Stocks Stories To Close Out the Trading Week

  Mark Lawson   | Fri, May 17 |  Comment
• 

  3 Healthcare Stock Earnings Snapshots

  Derek Hoffman   | Sat, May 4 |  Comment
• 

  Impax Laboratories Earnings: Everything You Must Know Now

  Derek Hoffman   | Wed, May 1 |  Comment
• 

  Vail Resorts’ Price Target Upped and 3 More Analyst Ratings to Read

  Alex Capel   | Thu, Mar 7 |  Comment
• 

  Impax Laboratories Earnings:Everything You Must Know Now

  Derek Hoffman   | Mon, Feb 25 |  Comment
• 

  Mexico Nixes Pfizer-Nestl頄eal, Impax Partners with Perrigo: Healthcare Biz Review

  Mark Lawson   | Thu, Nov 22 |  Comment
• 

  Hormel Sell-Off Viewed As Buying Opportunity and 4 Stock Analyses Buzzing Today

  Leah Powell   | Wed, Nov 21 |  Comment
• 

  Impax Q3 Results Linked To AstraZeneca, Amarin Wins Patent: Healthcare Biz Update

  Mark Lawson   | Tue, Oct 30 |  Comment
• 

  Quality Systems Lowered Due to Saturation and 4 Stock Analyses to Track

  Leah Powell   | Mon, Oct 15 |  Comment
• 

  Healthcare Business Wrap Up: Vivus's Class Action Suit Dismissed, Biolase's Good News

  Mark Lawson   | Thu, Oct 4 |  Comment
• 

  Healthcare Business Report: Life Technologies SHIPS Ion System, Omnicare's NEWS

  Mark Lawson   | Mon, Sep 17 |  Comment
• 

  Healthcare Biz Rewind: Amarin WINS FDA Approval, Impax SETTLES With Sanofi

  Mark Lawson   | Wed, Sep 5 |  Comment